Cargando…
Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression
Fatty liver disease (hepatosteatosis) is a common early pathology in alcohol-dependent and obese patients. Fatty acid binding protein-4 (FABP4) is normally expressed in adipocytes and macrophages and functions as a regulator of intracellular lipid movement/storage. This study sought to investigate h...
Autores principales: | Attal, Neha, Sullivan, Mariel T., Girardi, Cara A., Thompson, Kyle J., McKillop, Iain H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719965/ https://www.ncbi.nlm.nih.gov/pubmed/33290990 http://dx.doi.org/10.1016/j.tranon.2020.100975 |
Ejemplares similares
-
Role of AMPK-SREBP Signaling in Regulating Fatty Acid Binding-4 (FABP4) Expression following Ethanol Metabolism
por: Attal, Neha, et al.
Publicado: (2022) -
Right ventricular function and its relationship with grade of hepatosteatosis in non-alcoholic fatty liver disease
por: Bekler, Adem, et al.
Publicado: (2015) -
The association of laminin levels with insulin resistance and non-alcoholic hepatosteatosis
por: Altun, Özgür, et al.
Publicado: (2021) -
MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice
por: Miller, Ashley M., et al.
Publicado: (2013) -
A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis
por: Cho, Bennet S., et al.
Publicado: (2023)